Amira Guirguis: ‘We want to use our expertise to prepare for future threats’ As the recently appointed chair of the Royal Pharmaceutical Society’s science and research committee, Amira Guirguis sets out her goals for her new role and calls for more proactivity in the fight against substance misuse.…
Ability to supply naloxone should be expanded to non-registered members of pharmacy team, says negotiator Community Pharmacy England has said that amended legislation should go further than extending the ability to supply naloxone without a prescription to pharmacists and pharmacy technicians.…
Gene-editing sickle cell drug not approved for NHS use in draft NICE guidance The National Institute for Health and Care Excellence said it required “additional data” beyond the current proposal.…
MHRA reviewing safety of asthma drug as Yellow Card reports increase The Medicines and Healthcare products Regulatory Agency is reviewing montelukast after there were 143 reports of psychiatric disorders associated with the drug in 2023.…
First drug for severe alopecia recommended by NICE could benefit 14,000 patients Ritlecitinib (Litfulo; Pfizer), a once-daily oral pill, is the first licensed treatment recommended for patients with alopecia areata.…
UK regulator recommends new safety measures for medicines containing pseudoephedrine Safety information for all medicines containing pseudoephedrine will be updated to make clear the risk of rare, but serious, side effects.…
Pilots to provide PrEP via pharmacies only ‘possible future opportunities’, report warns A report from the HIV Action Plan Implementation Steering Group said it was “concerning that the current proposal for PrEP pilots is marked as ‘possible future opportunities’”.…
Changing the culture of fluoroquinolone prescribing Despite repeated warnings about disabling and irreversible side effects from fluoroquinolones, prescribing of these broad-spectrum antibiotics remains “stubbornly stable”.…
First-in-class antibiotic provides effective treatment for UTIs, trial results suggest Gepotidacin showed non-inferiority to nitrofurantoin in one trial and superiority in another.…
Erectile dysfunction drugs may reduce Alzheimer’s risk, study suggests Results from a study of more than 260,000 men has suggested those taking erectile dysfunction drugs were 18% less likely to develop Alzheimer's disease than those not taking the drugs.…
